EMA heads urges greater transparency for clinical drug trials

10/22/2013 | MedCityNews.com

Guido Rasi, executive director of the European Medicines Agency, says that the release of clinical trial data would increase efficiency and cost-effectiveness in drug development, becoming a boon to drug companies rather than creating the loss of competitive advantage they fear. His article, with EMA co-authors, appears in the New England Journal of Medicine. AbbVie and InterMune have filed lawsuits to prevent such data releases.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA